The CDC Guidelines recommend the use of a chlorhexidine-impregnated sponge dressing for temporary short term catheters when adherence to basic preventative measures has been unsuccessful.1, 2
Canada (FR)
true
- Overview
- Products & Accessories
- EIFU & Resources
Hightlights
true
GuardIVa™ Antimicrobial Hemostatic IV Dressing is an IV site care solution that combines the antimicrobial protection of chlorhexidine gluconate (CHG), a well-known antiseptic agent with broad spectrum antimicrobial and antifungal activity, with the proprietary hemostatic agent which controls surface bleeding from percutaneous catheters and vascular access sites.
Hemostasis
An in vivo animal test showed that, compared to gauze dressings, wounds treated with the GuardIVa® Dressing significantly reduced time to hemostasis and had up to 7 times less blood loss.3
Healing
An in vivo animal study showed that wounds treated with the GuardIVa™ Dressing healed at a rate comparable to untreated wounds, unlike BioPatch™.3
Antimicrobial
- Demonstrated in vitro antimicrobial efficacy against test organisms known to cause CRBSIs.3
- In vitro testing demonstrated sustained antimicrobial efficacy for up to 7 days. A greater than 4 log reduction in microbial count was observed for all test organisms.
- The GuardIVa™ dressing has not been clinically tested for its ability to reduce catheter-related blood stream infections.
1 Warnings: Do not use the GuardIVa® dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.
2 CDC Guidelines, 2011, pg 14. Category 1B
3 Data on file. Bard Access Systems, Inc., Salt Lake City, Utah. Results may not correlate to clinical performance.
INDICATIONS FOR USE:
The GuardIVa™ Antimicrobial Hemostatic IV Dressing is intended for use as a hydrophilic wound dressing to absorb exudate, cover and protect catheter sites. Common applications include IV catheters, other intravenous catheters and percutaneous devices. It is also indicated for control of surface bleeding from percutaneous catheters and vascular access sites.
WARNINGS:
Do not use the GuardIVa™ dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.
For external use only. Do not allow this product to contact ears, eyes, mouth or mucous membranes.
PRECAUTION:
GuardIVa™ dressing is not intended to treat infection.
Please consult product labels, IFU, and package inserts for any indications, contraindications, hazards, warnings, cautions, and instructions for use.
true
1 Warnings: Do not use the GuardIVa® dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.
2 CDC Guidelines, 2011, pg 14. Category 1B
3 Data on file. Bard Access Systems, Inc., Salt Lake City, Utah. Results may not correlate to clinical performance.
INDICATIONS FOR USE:
The GuardIVa™ Antimicrobial Hemostatic IV Dressing is intended for use as a hydrophilic wound dressing to absorb exudate, cover and protect catheter sites. Common applications include IV catheters, other intravenous catheters and percutaneous devices. It is also indicated for control of surface bleeding from percutaneous catheters and vascular access sites.
WARNINGS:
Do not use the GuardIVa™ dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.
For external use only. Do not allow this product to contact ears, eyes, mouth or mucous membranes.
PRECAUTION:
GuardIVa™ dressing is not intended to treat infection.
Please consult product labels, IFU, and package inserts for any indications, contraindications, hazards, warnings, cautions, and instructions for use.
true
Literature
BD's collection of literature on industry and on our offerings gives you information you can use to continue striving for excellence.
Learn more
Training
BD offers training resources to help improve your clinical practices as part of our goal of advancing the world of health.
Learn more
Events
BD supports the healthcare industry with market-leading products and services that aim to improve care while lowering costs. We host and take part in events that excel in advancing the world of health™.
Learn more
Case Studies
BD promotes clinical excellence by providing various resources on best practices, clinical innovations and industry trends in healthcare.
Learn more
1 Warnings: Do not use the GuardIVa® dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.
2 CDC Guidelines, 2011, pg 14. Category 1B
3 Data on file. Bard Access Systems, Inc., Salt Lake City, Utah. Results may not correlate to clinical performance.
INDICATIONS FOR USE:
The GuardIVa™ Antimicrobial Hemostatic IV Dressing is intended for use as a hydrophilic wound dressing to absorb exudate, cover and protect catheter sites. Common applications include IV catheters, other intravenous catheters and percutaneous devices. It is also indicated for control of surface bleeding from percutaneous catheters and vascular access sites.
WARNINGS:
Do not use the GuardIVa™ dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.
For external use only. Do not allow this product to contact ears, eyes, mouth or mucous membranes.
PRECAUTION:
GuardIVa™ dressing is not intended to treat infection.
Please consult product labels, IFU, and package inserts for any indications, contraindications, hazards, warnings, cautions, and instructions for use.
true
true
